Biocryst Pharmaceuticals (BCRX) Gross Margin (2010 - 2026)
Biocryst Pharmaceuticals (BCRX) recorded Gross Margin of 98.24% in Q2 2026, down 0.05 percentage points from 98.29% a year earlier but up 1.68 percentage points from the prior quarter.
Powered by 
Analysis
Biocryst Pharmaceuticals (BCRX) Gross Margin (2010 - 2026) Analysis & Trends
On a TTM basis, Biocryst Pharmaceuticals' Gross Margin came in at 97.78% as of Jun 30, 2026, up 0.77 percentage points year-over-year; for FY2025, it came in at 97.82%, up 0.54 percentage points from FY2024.
- Annual Gross Margin has a five-year change of +6.52 percentage points (FY2020 to FY2025).
- Across earlier years, Gross Margin came in at 97.28% in FY2024 (-1.37 pp), 98.65% in FY2023 (+1.01 pp), 97.63% in FY2022 (+2.23 pp) and 95.40% in FY2021 (+4.10 pp).
- Quarterly Gross Margin has ranged from 95.33% in Q3 2022 to 99.62% in Q2 2022 over the past five years.
- On a year-over-year basis, Gross Margin rose in two of the last eight quarters, with an average year-over-year change of -0.38 percentage points.
- Peak year-over-year performance for Gross Margin in the last five years was a gain of 30.60 percentage points in Q1 2022, against a drop of 3.23 percentage points in Q3 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at 96.56% (Q1 2026), 97.66% (Q4 2025) and 98.63% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 68.19% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 74.74% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 73.54% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 78.02% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 83.60% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 72.04% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 79.76% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 72.78% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 85.33% |
| 10 | Biocryst Pharmaceuticals | 2.16 Bn | 1.08 Bn | 214.41 Mn | 98.24% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 98.24% |
| Mar 31, 2026 | 96.56% |
| Dec 31, 2025 | 97.66% |
| Sep 30, 2025 | 98.63% |
| Jun 30, 2025 | 98.29% |
| Mar 31, 2025 | 96.86% |
| Dec 31, 2024 | 95.37% |
| Sep 30, 2024 | 97.26% |
| Jun 30, 2024 | 98.45% |
| Mar 31, 2024 | 98.64% |
| Dec 31, 2023 | 98.33% |
| Sep 30, 2023 | 98.73% |
| Jun 30, 2023 | 98.92% |
| Mar 31, 2023 | 98.65% |
| Dec 31, 2022 | 97.00% |
| Sep 30, 2022 | 95.33% |
| Jun 30, 2022 | 99.62% |
| Mar 31, 2022 | 99.53% |
| Dec 31, 2021 | 99.11% |
| Sep 30, 2021 | 98.56% |
API Access
Biocryst Pharmaceuticals Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=BCRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "BCRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=BCRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();